← SynDRA
DR-2313
SynDRA canonical compound SYN0060927 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PARP1 | PARP3 |
| Mechanism of action | PARP inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- RefChem:475280
- 2-Methyl-3,5,7,8-tetrahydrothiopyrano(4,3-d)pyrimidine-4-one
- 7,8-Dihydro-2-methyl-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one
- DR2313
- Parp inhibitor xi
- MFCD08703132
- IR 2313
- 4GM3843TP6
- 2-methyl-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one
- 2-Methyl-1,5,7,8-tetrahydro-thiopyrano(4,3-d)pyrimidin-4-one
- 2-Methyl-1,5,7,8-tetrahydrothiopyrano(4,3-d)pyrimidin-4-one
- 4pnl
- DRL
- 3c4h
- SCHEMBL421328
- UNII-4GM3843TP6
- orb1305823
- SCHEMBL15105584
- HMS3269K13
- HMS3413D09
- HMS3677D09
- 2-methyl-7,8-dihydro-1H-thiopyrano[4,3-d]pyrimidin-4(5H)-one
- 2-methyl-7,8-dihydro-3H-thiopyrano[4,3-d]pyrimidin-4(5H)-one
- EX-A5260
- BDBM50277614
- AKOS006291031
- AKOS025401612
- DR2313?
- NCGC00167745-01
- AC-22822
- AS-35194
- DB-024851
- DR2313, >=98% (HPLC)
- HY-105692
- CS-0026455
- NS00071005
- F223468
- BRD-K94920105-001-01-3
- BRD-K94920105-001-03-9
Look up DR-2313 in the interactive SynDRA portal →